These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 21050175)

  • 1. The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications.
    Zaveri NT
    Curr Top Med Chem; 2011; 11(9):1151-6. PubMed ID: 21050175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Nociceptin Receptor (NOP) Agonist AT-312 Blocks Acquisition of Morphine- and Cocaine-Induced Conditioned Place Preference in Mice.
    Zaveri NT; Marquez PV; Meyer ME; Hamid A; Lutfy K
    Front Psychiatry; 2018; 9():638. PubMed ID: 30555362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the NOP receptor agonist Ro65-6570 on the acquisition of opiate- and psychostimulant-induced conditioned place preference in rats.
    Rutten K; De Vry J; Bruckmann W; Tzschentke TM
    Eur J Pharmacol; 2010 Oct; 645(1-3):119-26. PubMed ID: 20674566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ro 64-6198 [(1S,3aS)-8-(2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one] acts differently from nociceptin/orphanin FQ in rat periaqueductal gray slices.
    Chiou LC; Chuang KC; Wichmann J; Adam G
    J Pharmacol Exp Ther; 2004 Nov; 311(2):645-51. PubMed ID: 15254141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats.
    Micheli L; Di Cesare Mannelli L; Guerrini R; Trapella C; Zanardelli M; Ciccocioppo R; Rizzi A; Ghelardini C; Calò G
    Eur J Pharmacol; 2015 May; 754():73-81. PubMed ID: 25704616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.
    Khroyan TV; Polgar WE; Jiang F; Zaveri NT; Toll L
    J Pharmacol Exp Ther; 2009 Dec; 331(3):946-53. PubMed ID: 19713488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of nociceptin/orphanin FQ receptors inhibits contextual fear memory reconsolidation.
    Rekik K; Faria Da Silva R; Colom M; Pacifico S; Zaveri NT; Calo' G; Rampon C; Frances B; Mouledous L
    Neuropharmacology; 2017 Oct; 125():39-49. PubMed ID: 28705439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Deletion of the Nociceptin/Orphanin FQ Receptor in the Rat Confers Resilience to the Development of Drug Addiction.
    Kallupi M; Scuppa G; de Guglielmo G; Calò G; Weiss F; Statnick MA; Rorick-Kehn LM; Ciccocioppo R
    Neuropsychopharmacology; 2017 Feb; 42(3):695-706. PubMed ID: 27562376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of the nociceptin/orphanin FQ receptor on ethanol-mediated motivational effects in infant and adolescent rats.
    Miranda-Morales RS; Pautassi RM
    Behav Brain Res; 2016 Feb; 298(Pt A):88-96. PubMed ID: 25907741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nociceptin/orphanin FQ receptors modulate the discriminative stimulus effects of oxycodone in C57BL/6 mice.
    Walentiny DM; Wiebelhaus JM; Beardsley PM
    Drug Alcohol Depend; 2018 Jun; 187():335-342. PubMed ID: 29705547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOP-Related Mechanisms in Substance Use Disorders.
    Ciccocioppo R; Borruto AM; Domi A; Teshima K; Cannella N; Weiss F
    Handb Exp Pharmacol; 2019; 254():187-212. PubMed ID: 30968214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nociceptin Receptors Upregulated in Cocaine Use Disorder: A Positron Emission Tomography Imaging Study Using [
    Narendran R; Tollefson S; Himes ML; Paris J; Lopresti B; Ciccocioppo R; Mason NS
    Am J Psychiatry; 2019 Jun; 176(6):468-476. PubMed ID: 31055968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys.
    Ko MC; Woods JH; Fantegrossi WE; Galuska CM; Wichmann J; Prinssen EP
    Neuropsychopharmacology; 2009 Aug; 34(9):2088-96. PubMed ID: 19279568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nociceptin/orphanin FQ/NOP receptor system as a target for treatment of alcohol abuse: a review of recent work in alcohol-preferring rats.
    Ciccocioppo R; Economidou D; Fedeli A; Massi M
    Physiol Behav; 2003 Jun; 79(1):121-8. PubMed ID: 12818717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional heterogeneity of nociceptin/orphanin FQ receptors revealed by (+)-5a Compound and Ro 64-6198 in rat periaqueductal grey slices.
    Liao YY; Teng SF; Lin LC; Kolczewski S; Prinssen EP; Lee LJ; Ho IK; Chiou LC
    Int J Neuropsychopharmacol; 2011 Aug; 14(7):977-89. PubMed ID: 21029514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orphanin FQ/nociceptin but not Ro 65-6570 inhibits the expression of cocaine-induced conditioned place preference.
    Kotlińska J; Wichmann J; Legowska A; Rolka K; Silberring J
    Behav Pharmacol; 2002 May; 13(3):229-35. PubMed ID: 12122313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Nociceptin/Orphanin FQ-NOP Receptor System in the Regulation of Stress-Related Disorders.
    Ubaldi M; Cannella N; Borruto AM; Petrella M; Micioni Di Bonaventura MV; Soverchia L; Stopponi S; Weiss F; Cifani C; Ciccocioppo R
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test.
    Rizzi A; Ruzza C; Bianco S; Trapella C; Calo' G
    Peptides; 2017 Aug; 94():71-77. PubMed ID: 28697954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first universal opioid ligand, (2S)-2-[(5R,6R,7R,14S)-N-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylpentan-2-ol (BU08028): characterization of the in vitro profile and in vivo behavioral effects in mouse models of acute pain and cocaine-induced reward.
    Khroyan TV; Polgar WE; Cami-Kobeci G; Husbands SM; Zaveri NT; Toll L
    J Pharmacol Exp Ther; 2011 Mar; 336(3):952-61. PubMed ID: 21177476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.